Evidence map›Paper›PMID 25867459›Full record

ArticlePloS one2015

Phosphatidylinositol-glycan-phospholipase D is involved in neurodegeneration in prion disease.

Jae-Kwang Jin, Byungki Jang, Hyoung Tae Jin, Eun-Kyoung Choi, Cha-Gyun Jung, Hiroyasu Akatsu, Jae-Il Kim, Richard I Carp, Yong-Sun Kim

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Exploring the PLD1-tau interaction in Frontotemporal Dementia.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Jae-Kwang JinIlsong Institute of Life Science, Hallym University, Anyang, Gyeonggi-do 431-060, Korea.
Byungki JangIlsong Institute of Life Science, Hallym University, Anyang, Gyeonggi-do 431-060, Korea.
Hyoung Tae JinIlsong Institute of Life Science, Hallym University, Anyang, Gyeonggi-do 431-060, Korea.
Eun-Kyoung ChoiIlsong Institute of Life Science, Hallym University, Anyang, Gyeonggi-do 431-060, Korea.
Cha-Gyun JungDepartment of Neurophysiology and Brain Science, Nagoya City University Graduate, School of Medical Sciences, Nagoya, Aichi 467-8601, Japan.
Hiroyasu AkatsuChoju Medical Institute, Fukushimura Hospital, Toyohashi 441-8124, Japan.
Jae-Il KimDepartment of Food Science and Nutrition, Pukyong National University, Busan 608-737, Korea.
Richard I CarpDepartment of Virology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, United States of America.
Yong-Sun KimIlsong Institute of Life Science, Hallym University, Anyang, Gyeonggi-do 431-060, Korea.
Hallym University · KRFukushimura Hospital · JPNew York State Office for People With Developmental Disabilities · USPukyong National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PrPSc is formed from a normal glycosylphosphatidylinositol (GPI)-anchored prion protein (PrPC) by a posttranslational modification. Most GPI-anchored proteins have been shown to be cleaved by GPI phospholipases. Recently, GPI-phospholipase D (GPI-PLD) was shown to be a strictly specific enzyme for GPI anchors. To investigate the involvement of GPI-PLD in the processes of neurodegeneration in prion diseases, we examined the mRNA and protein expression levels of GPI-PLD in the brains of a prion animal model (scrapie), and in both the brains and cerebrospinal fluids (CSF) of sporadic and familial Creutzfeldt-Jakob disease (CJD) patients. We found that compared with controls, the expression of GPI-PLD was dramatically down-regulated in the brains of scrapie-infected mice, especially in the caveolin-enriched membrane fractions. Interestingly, the observed decrease in GPI-PLD expression levels began at the same time that PrPSc began to accumulate in the infected brains and this decrease was also observed in both the brain and CSF of CJD patients; however, no differences in expression were observed in either the brains or CSF specimens from Alzheimer's disease patients. Taken together, these results suggest that the down-regulation of GPI-PLD protein may be involved in prion propagation in the brains of prion diseases.

Indexed as

AgedAged, 80 and overAnimalsBrainFemaleHumansMaleMiceMice, Inbred C57BLMiddle AgedNeurodegenerative DiseasesPhospholipase DPrion Diseasesglycoprotein phospholipase DPhospholipase D

Identifiers

PMID25867459
PMCPMC4395093
OpenAlexW2083912366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.